Nikki Schultek, founder of the global medical research consortium Intracell Research Group, takes a close look at how the COVID-19 pandemic may prompt a…
Cassava Sciences continues to push back on allegations of scientific misconduct around newly released trial data for their investigational Alzheimer’s drug simufilam. Early data…
In our LiveTalk series, Being Patient explored the inner workings of the Wisconsin Registry for Alzheimer’s Prevention, a long-running study of people at risk…
University of Montreal neuropsychology PhD student Émilie Delage, University of Quebec at Montreal professor of psychology and neuropsychology Isabelle Rouleau and University of Montreal…
IMAGE: Photobiomodulation tabletop device Beacon40 by neurotechnology company Bright Could flickering lights have brain health benefits? Research around experimental therapies involving external stimuli —…
Being Patient reporter Simon Spichak, who researches the role of microbes and aging at APC Microbiome Ireland, University College Cork, demystifies the microbiome and…
A recent study of immune cells derived from human stem cells shows that experimental antibodies for Parkinson’s and Alzheimer’s can trigger harmful brain inflammation,…